Investor communication

Investor communication

 For institutional clients, please contact one of our product specialist.

Product specialist Arctic Aurora LifeScience:

Norway
Vegard Gjølme
Partner, Institutional Sales
Arctic Fund Management

Phone:   +47 2101 3100
Direct:    +47 2101 3253
Mobile:   +47 4840 3253
E-mail:   vegard.gjoelme@arctic.com

Sweden
Anna Jakobson
CEFA, Institutional Sales
Arctic Fund Management

Phone:    +46 8 446 86078
Mobile:    +46 720 509024
E-mail:    anna.jakobson@arctic.com

 

 

Arctic Aurora LifeScience is an equity fund investing in global biotechnology and pharmaceutical companies. The fund is run by former portfolio manager in the Swedish AP3 Fonder, Ulrica Bjerke, as well as Dr. Torbjørn Bjerke, both with 20 years of experience from the market. Arctic Aurora LifeScience was launched in May 2016 with both hedged and un-hedged share classes.

Past performance in Arctic Aurora LifeScience is no guarantee for future returns. Future returns depend on the market, fund manager skill, fund risk level, costs, among others. Performance in the fund may at times be negative and may for this fund vary considerably within periods.